Quantinno Capital Management LP Has $3.36 Million Stock Holdings in iShares Biotechnology ETF $IBB

Quantinno Capital Management LP boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 33.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,892 shares of the financial services provider’s stock after purchasing an additional 4,939 shares during the quarter. Quantinno Capital Management LP’s holdings in iShares Biotechnology ETF were worth $3,359,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of IBB. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter valued at about $25,000. Basepoint Wealth LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $26,000. Cary Street Partners Financial LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $29,000. Copia Wealth Management acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at about $34,000. Finally, Caitlin John LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at about $34,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $197.71 on Friday. The firm has a 50 day moving average price of $183.84 and a two-hundred day moving average price of $175.35. iShares Biotechnology ETF has a 12-month low of $131.36 and a 12-month high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.